Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Sep 9, 2022
Open Peer Review Period: Sep 9, 2022 - Nov 4, 2022
Date Accepted: Nov 21, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Ahmed F, Memon N, Haque A

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

JMIR Dermatol 2022;5(4):e41739

DOI: 10.2196/41739

PMID: 36504544

PMCID: 9720466

Multiple keratoacanthomas following the Moderna mRNA-1273 Covid-19 vaccination resolved with 5-FU treatment: Case Report

  • Fahad Ahmed; 
  • Nashwah Memon; 
  • Adel Haque

ABSTRACT

Cutaneous reactions have been commonly associated with the Moderna mRNA Covid-19 vaccine. Of the reported cutaneous side effects, there have not been any associations reported yet of keratoacanthoma after Covid-19 mRNA vaccination. We report a novel case of an 86 year old man who had an eruption of multiple keratoacanthomas 2 weeks after inoculation with the Moderna mRNA-1273 vaccine that resolved following treatment with intralesional 5-fluorouracil.


 Citation

Please cite as:

Ahmed F, Memon N, Haque A

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

JMIR Dermatol 2022;5(4):e41739

DOI: 10.2196/41739

PMID: 36504544

PMCID: 9720466

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.